Literature DB >> 17046096

Immunotherapy of hepatocellular carcinoma.

Tim F Greten1, Michael P Manns, Firouzeh Korangy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17046096     DOI： 10.1016/j.jhep.2006.09.004

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  28 in total

Review 1.  Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches.

Authors:  Tim F Greten; Xin W Wang; Firouzeh Korangy
Journal:  Gut       Date:  2015-02-09       Impact factor: 23.059

2.  Human CCR4+ CCR6+ Th17 cells suppress autologous CD8+ T cell responses.

Authors:  Fei Zhao; Bastian Hoechst; Jaba Gamrekelashvili; Lars A Ormandy; Torsten Voigtländer; Heiner Wedemeyer; Kris Ylaya; Xin Wei Wang; Stephen M Hewitt; Michael P Manns; Firouzeh Korangy; Tim F Greten
Journal:  J Immunol       Date:  2012-05-21       Impact factor: 5.422

Review 3.  Potentiality of immunotherapy against hepatocellular carcinoma.

Authors:  Nobuhiro Tsuchiya; Yu Sawada; Itaru Endo; Yasushi Uemura; Tetsuya Nakatsura
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

Review 4.  Targets for immunotherapy of liver cancer.

Authors:  Tim F Greten; Bruno Sangro
Journal:  J Hepatol       Date:  2017-09-18       Impact factor: 25.083

5.  A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma.

Authors:  Tim F Greten; Alejandro Forner; Firouzeh Korangy; Gisele N'Kontchou; Nathalie Barget; Carmen Ayuso; Lars A Ormandy; Michael P Manns; Michel Beaugrand; Jordi Bruix
Journal:  BMC Cancer       Date:  2010-05-17       Impact factor: 4.430

Review 6.  Cellular immune suppressor mechanisms in patients with hepatocellular carcinoma.

Authors:  Fei Zhao; Firouzeh Korangy; Tim F Greten
Journal:  Dig Dis       Date:  2012-10-24       Impact factor: 2.404

Review 7.  Trends in the treatment of advanced hepatocellular carcinoma: immune checkpoint blockade immunotherapy and related combination therapies.

Authors:  Huijuan Cheng; Guodong Sun; Hao Chen; Yu Li; Zhijian Han; Yangbing Li; Peng Zhang; Luxi Yang; Yumin Li
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

8.  Hepatocellular carcinoma from an immunologic perspective.

Authors:  Tim F Greten; Austin G Duffy; Firouzeh Korangy
Journal:  Clin Cancer Res       Date:  2013-09-12       Impact factor: 12.531

Review 9.  Translational medicine in hepatocellular carcinoma.

Authors:  Qiang Gao; Yinghong Shi; Xiaoying Wang; Jian Zhou; Shuangjian Qiu; Jia Fan
Journal:  Front Med       Date:  2012-05-09       Impact factor: 4.592

10.  Consensus of Minimally Invasive and Multidisciplinary Comprehensive Treatment for Hepatocellular Carcinoma - 2020 Guangzhou Recommendations.

Authors:  Qi-Feng Chen; Wang Li; Simon Chun-Ho Yu; Yi-Hong Chou; Hyunchul Rhim; Xiaoming Yang; Lujun Shen; Annan Dong; Tao Huang; Jinhua Huang; Fujun Zhang; Weijun Fan; Ming Zhao; Yangkui Gu; Zhimei Huang; Mengxuan Zuo; Bo Zhai; Yueyong Xiao; Ming Kuang; Jiaping Li; Jianjun Han; Wei Song; Jie Ma; Peihong Wu
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.